1.

INBOUND LOGISTICS :-

PHARMA IN-BOUND LOGISTICS ARE MOSTLY DEALT WITH CHEMICAL

SUPPLYING ENTITIES TO GASSES AND EQUIPMENTS FOR PROPER R&D OR
PRODUCTION.

OBTAINING LICENCE FOR CONDUCTING RESEARCH OR DRUG TRIALS

LICENSES TO PRODUCE THOSE MEDICATIONS

HIGH INDULGEMENT OF GOVERNANCE IN THE INDUSTRY TO CONTROL

AND SUPPLY IT HAS SPECIFIC KIND OF VEHICLES.

2. OITBOUND LOGISTICS :-

POST R&D ON MEDICATIONS APPROVAL OF PUBLIC DISTRIBUTION.

BATCHES OF MEDICATIONS ARE FIRST HAS GONE THROUGH VIGORUS

DURING PRE-PRODUCTION OF THOSE APPROVED MEDICATIONS.

SPECIALIZED TRANSPORTATION IS HANDLED FOR DELIVERING.

 3. OPERATIONS :- MAINLY OPRETIONS & MARKETING OF CIPLA GO HAND-
IN-HAND AS A;; CAMPAINGNS AND DRUG LAUNCHES IS DONE THROUGH
AWARENESS CAMPAINGNS
THEY ARE OPERATING WITH WATER CARBON NUETRALITY
ZERO WASTE TO LANDFILL
GREEN CHEMISTRY
REDUCTION OF GREEN HOUSE GASSES
ZERO FATALITIES DURING PRODUCTION & OPERATIONS
FIXED FORCE FOR REGOROS SALES AND AWARENESS BRANCHES.

4. MARKETING :-
Business through Building direct patient connect (B2C)
Increased digital outreach for Channel & Customer India’s first digital educator for patients on inhaler device use.

India’s first digital educator for patients on inhaler device use. A video-based counselling service that has counselled
around 11,000 patients so far

SYNERGIZED DISTRIBUTION & improving access with therapies on digi plat:- A video-based counselling service that
has counselled around 11,000 patients so far Cipla's first-ever global web-series programme featuring key opinion
leaders and therapy area experts.

Four global shows hosted in five international languages & 16 LOCAL LANGUAUGES Cipla and GoApptiv partnered to
expand channel reach across tier 3 towns in India

Easily accessible in the drug store

Reimagining field force engagements with Healthcare Professionals (HCPs) in international markets

ONE-INDIA Strategy led by portfolio expansion

Equal cipla initiative

Nicotex

Segmentation
 5. INFRASTRUCTURE :-
80 countries with 46 state-of-the-art manufacturing facilities producing over 1,500 products.

Cipla is the third-largest pharma company in India (IQVIA March 2021) and the third largest in the private
pharma market of South Africa (IQVIA March 2021).

We are the largest Indian exporter to emerging markets and also amongst the most dispensed generic
players in the US.

R&D FACILITIES

DRUG TRIAL FACILITIES

ASSESSMENT OF NEWLY INVENTED STUDIES AND 4IN1 FORMULATION IN

HIVA ND VARIOUS SERIOUS AILMENTS.

TECHNOLOGY :-
Industry 4.0 and Automation in Manufacturing

Implementation of Continuous Manufacturing; Continued momentum on Environment Sustainability

Paper-less, Touch-less, Automated Quality Labs

Automation of processes minimising scope for errors, increasing throughput and reducing quality release turnaround
timelines

6. HRM :-
Digital Esproute :- Consistent, seamless onboarding and induction for all Cipla recruits globally
Cipla University :- Virtual upskilling programmes for employees TRAINED 3LAKH WORKFORCE
Future of Work :- Hybrid working models using digital platforms for employee safety, productivity and
engagement
CERTIFIED GREAT PLACE TO WORK AWARD
MENTAL & SOCIAL WELL BEIMG FOR EMPLOYEES & PARTNERS.
14% OF WOMEN WORKFORCE ENVIROMENT & 1/3RD OF MANMT COUNCIL IS WOMEN.
24*7 AMBULANCE AND PARAMEDICAL TEAM AVAILAIBLE AT ALL FACILITIES FOR QUICK RESPONSE.
GENERATING EMPLOYMENT IN TIER 3 CITIES HIRING FRESH AND YOUNF TALENTS ACROSS.

7. PROCUREMENT :- PROCUREMNT OF GASSES AND CHEMICALS.

HUMAN TO CREATE STUDIES ON THEM WHO IS SUFFERRING FROM THAT
AILMENT.